Figure S5 from EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression

2026 Open access

Read full text
Authors: Justine J. Jacobi, Kristine M. Wadosky, Neha Jaiswal, Xiaojing Zhang, Yanqing Wang, Prashant K. Singh, Jie Wang, Eduardo Cortes Gomez, Jianmin Wang, Bo Xu, Mark D. Long, Paloma Cejas
+3 more Shweta Kukreja, Henry W. Long, David W. Goodrich
DOI: 10.1158/0008-5472.31345577
Cited by: 0

Abstract

Ezh2 deficiency alters transcription factor activity and PrCa lineage subtype evolution

Fields of Study & Subjects

Prostate Cancer Treatment and Research Epigenetics and DNA Methylation Chromatin Remodeling and Cancer

Publication details

Publication date
16 February 2026
Language
EN